0 code page views remaining today. Guest accounts are limited to 2 daily page views. Register free account to get more views.

Log in Register free account

Measure Groups for Quality Payment Program

Measures 400-499

G8633-G9457
Measures 300-399

G9341-G9757
Measure 404: Anesthesiology Smoking Abstinence

G9497-G9645
Measure 411: Depression Remission at Six Months

G9511-G9511
Measure 415: Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older

G9529-G9533
Measure 419: Overuse Of Neuroimaging For Patients With Primary Headache And A Normal Neurological Examination

G9537-G9537
Measure 421: Appropriate Assessment of Retrievable Inferior Vena Cava (IVC) Filters for Removal

G9539-G9544
Measure 406: Appropriate Follow-up Imaging for Incidental Thyroid Nodules in Patients

G9552-G9556
Measure 413: Door to Puncture Time for Endovascular Stroke Treatment

G9580-G9767
Measure 416: Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 Through 17 Years

G9593-G9597
Measure 420: Varicose Vein Treatment with Saphenous Ablation: Outcome Survey

G9603-G9605
Measure 422: Performing Cystoscopy at the Time of Hysterectomy for Pelvic Organ Prolapse to Detect Lower Urinary Tract Injury

G9606-G9608
Measure 423: Perioperative Anti-platelet Therapy for Patients Undergoing Carotid Endarterectomy

G9609-G9611
Measure 431: Preventive Care and Screening: Unhealthy Alcohol Use: Screening & Brief Counseling

G9621-G9624
Measure 432: Proportion of Patients Sustaining a Bladder Injury at the Time of any Pelvic Organ Prolapse Repair

G9625-G9627
Measure 433: Proportion of Patients Sustaining a Bowel Injury at the time of any Pelvic Organ Prolapse Repair

G9628-G9630
Measure 436: Radiation Consideration for Adult CT: Utilization of Dose Lowering Techniques

G9637-G9638
Measure 409: Clinical Outcome Post Endovascular Stroke Treatment

G9646-G9648
Measure 410: Psoriasis: Clinical Response to Oral Systemic or Biologic Medications

G9649-G9765
Measure 424: Perioperative Temperature Management

G9654-G9773
Measure 426: Post-Anesthetic Transfer of Care Measure: Procedure Room to a Post Anesthesia Care Unit (PACU)

G9655-G9658
Measure 439: Age Appropriate Screening Colonoscopy

G9659-G9661
Measure 438: Statin Therapy for the Prevention and Treatment of Cardiovascular Disease

G9662-G9782
Measure 414: Evaluation or Interview for Risk of Opioid Misuse

G9683-G9685
Measure 430: Prevention of Post-Operative Nausea and Vomiting (PONV) – Combination Therapy

G9775-G9777
Measure 440: Basal Cell Carcinoma (BCC)/Squamous Cell Carcinoma: Biopsy Reporting Time – Pathologist to Clinician

G9784-G9784
Measure 441: Ischemic Vascular Disease (IVD) All or None Outcome Measure (Optimal Control)

G9787-G9797
Measure 443: Non-Recommended Cervical Cancer Screening in Adolescent Females

G9805-G9807
Measure 445: Risk-Adjusted Operative Mortality for Coronary Artery Bypass Graft (CABG)

G9812-G9813
Measure 447: Chlamydia Screening and Follow Up

G9818-G9821
Measure 448: Appropriate Workup Prior to Endometrial Ablation

G9822-G9824
Measure 450: Trastuzumab Received By Patients With AJCC Stage I (T1c) – III And HER2 Positive Breast Cancer Receiving Adjuvant Chemotherapy

G9830-G9832
Measure 451: KRAS Gene Mutation Testing Performed for Patients with Metastatic Colorectal Cancer who receive Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibody Therapy

G9838-G9841
Measure 452: Patients with Metastatic Colorectal Cancer and KRAS Gene Mutation Spared Treatment with Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibodies

G9842-G9845
Measure 453: Proportion Receiving Chemotherapy in the Last 14 Days of Life

G9846-G9847
Measure 457: Proportion Admitted to Hospice for less than 3 days

G9858-G9861
Measure 459: Average Change in Back Pain following Lumbar Discectomy / Laminotomy

G9943-G9943
Measure 460: Average Change in Back Pain following Lumbar Fusion

G9946-G9946
Measure 463: Prevention of Post-Operative Vomiting (POV) - Combination Therapy (Pediatrics)

G9954-G9958
Measure 464: Otitis Media with Effusion (OME): Systemic Antimicrobials- Avoidance of Inappropriate Use

G9959-G9961
Measure 465: "Uterine Artery Embolization Technique: Documentation of Angiographic Endpoints and Interrogation of Ovarian Arteries"

G9962-G9963
Measure 466: Well-child Visits

G9964-G9965